Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand.
Alana L WhitcombeReuben McGregorAlyson CraigieAlex JamesRichard CharlewoodNatalie LorenzJames Mj DicksonCampbell R SheenBarbara KochShivani Fox-LewisGary McAuliffeSally A RobertsSusan C MorpethSusan TaylorRachel H WebbSusan JackArlo UptonJames E UssherNicole J MorelandPublished in: Clinical & translational immunology (2021)
Antibodies to SARS-CoV-2 persist for up to 8 months following mild-to-moderate infection. This robust response can be attributed to the initial exposure without immune boosting given the lack of community transmission in our setting.